Form 4: Calix Director Sells Shares Under 10b5-1 Plan

Calix, Inc. Director Carl Russo reported the sale of 25,000 shares of common stock, valued at approximately $1.8 million, executed under a pre-arranged trading plan.

Summary

• Director Carl Russo sold a total of 25,000 shares of Calix, Inc. common stock.
• The sales occurred on April 27, 2026.
• The transactions were conducted under a Rule 10b5-1 trading plan adopted on April 25, 2025.
• The weighted average sale price for the first transaction was $43.1689, and for the second transaction was $43.7502.
• Following these transactions, Russo beneficially owns 1,648,279 shares indirectly through The Crescentico Trust (Carl Russo, Trustee) and 3,953,070 shares directly.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as slightly negative due to the significant sale of shares by a director, despite the use of a 10b5-1 plan, which can signal a lack of immediate positive conviction from an insider.

Positives

• The sales were executed under a Rule 10b5-1 trading plan, indicating pre-planned and potentially non-insider trading related activity.
• The reporting person, Carl Russo, is a Director and a 10% owner of Calix, Inc., suggesting significant alignment with the company's performance.

Negatives

• A significant number of shares (25,000) were sold by a key insider.
• The total value of shares sold is approximately $1.8 million, which could be perceived as a lack of confidence by an insider.

Risks

• Potential for negative market perception due to insider selling, even if conducted under a 10b5-1 plan.
• The specific reasons for the sale are not detailed, leaving room for speculation.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports on past transactions.

Management Comments

• The sales reported on the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 25, 2025.

Industry Context

StockSavvy.ai notes that insider selling, particularly by directors, is a common event in the technology sector. The use of Rule 10b5-1 plans is a standard practice to mitigate concerns about insider trading, allowing executives to diversify their holdings or meet personal financial needs in a structured manner.

Stakeholder Impact

• Shareholders may view the insider selling with caution, potentially leading to short-term downward pressure on the stock price.
• Employees with stock options or grants may be influenced by the director's selling activity.
• Creditors and suppliers are unlikely to be directly impacted by this transaction.

Next Steps

• Monitor future Form 4 filings for any further transactions by Carl Russo or other insiders.
• Observe the company's stock performance following this insider selling activity.

Key Dates

Recommendation

While the sale of shares by a director is a negative signal, the fact that it was executed under a Rule 10b5-1 plan mitigates concerns about immediate negative insights into the company's prospects. The holding recommendation reflects a neutral stance, awaiting further company performance data rather than reacting solely to this insider transaction.

Keywords

Calix Inc, CALX, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Director, Beneficial Ownership, Securities Exchange Act